Found: 25
Select item for more details and to access through your institution.
In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapy.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05702-0
- By:
- Publication type:
- Article
B cell‐intrinsic MyD88 signaling controls IFN‐γ‐mediated early IgG2c class switching in mice in response to a particulate adjuvant.
- Published in:
- European Journal of Immunology, 2019, v. 49, n. 9, p. 1433, doi. 10.1002/eji.201848084
- By:
- Publication type:
- Article
A clinically applicable adjuvant for an atherosclerosis vaccine in mice.
- Published in:
- European Journal of Immunology, 2018, v. 48, n. 9, p. 1580, doi. 10.1002/eji.201847584
- By:
- Publication type:
- Article
Species-dependent role of type I IFNs and IL-12 in the CTL response induced by humanized CpG complexed with β-glucan.
- Published in:
- European Journal of Immunology, 2016, v. 46, n. 5, p. 1142, doi. 10.1002/eji.201546059
- By:
- Publication type:
- Article
TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.
- Published in:
- European Journal of Immunology, 2015, v. 45, n. 4, p. 1159, doi. 10.1002/eji.201445132
- By:
- Publication type:
- Article
Development of Nonaggregating Poly-A Tailed Immunostimulatory A/D Type CpG Oligodeoxynucleotides Applicable for Clinical Use.
- Published in:
- 2015
- By:
- Publication type:
- journal article
In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapy.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05702-0
- By:
- Publication type:
- Article
Machine Learning-Assisted Screening of Herbal Medicine Extracts as Vaccine Adjuvants.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.847616
- By:
- Publication type:
- Article
Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2013, v. 3, p. 1, doi. 10.3389/fcimb.2012.00168
- By:
- Publication type:
- Article
DNA released from dying host cells mediates aluminum adjuvant activity.
- Published in:
- Nature Medicine, 2011, v. 17, n. 8, p. 996, doi. 10.1038/nm.2403
- By:
- Publication type:
- Article
RNA is an Adjuvanticity Mediator for the Lipid-Based Mucosal Adjuvant, Endocine.
- Published in:
- Scientific Reports, 2016, p. 29165, doi. 10.1038/srep29165
- By:
- Publication type:
- Article
T helper 17 Promotes induction of antigen-specific gut-Mucosal cytotoxic T lymphocytes following adenovirus Vector Vaccination.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01456
- By:
- Publication type:
- Article
The Chemotherapeutic Agent DMXAA as a Unique IRF3-Dependent Type-2 Vaccine Adjuvant.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0060038
- By:
- Publication type:
- Article
Akkermansia muciniphila induces slow extramedullary hematopoiesis via cooperative IL‐1R/TLR signals.
- Published in:
- EMBO Reports, 2023, v. 24, n. 12, p. 1, doi. 10.15252/embr.202357485
- By:
- Publication type:
- Article
Cyclic GMP-AMP Triggers Asthma in an IL-33-Dependent Manner That Is Blocked by Amlexanox, a TBK1 Inhibitor.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.02212
- By:
- Publication type:
- Article
Deleting interleukin-10 from myeloid cells exacerbates atherosclerosis in Apoe<sup>−/−</sup> mice.
- Published in:
- Cellular & Molecular Life Sciences, 2023, v. 80, n. 1, p. 1, doi. 10.1007/s00018-022-04649-9
- By:
- Publication type:
- Article
Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome.
- Published in:
- Nature Communications, 2014, v. 5, n. 3, p. 3492, doi. 10.1038/ncomms4492
- By:
- Publication type:
- Article
Plasmacytoid Dendritic Cells Delineate Immunogenicity of Influenza Vaccine Subtypes.
- Published in:
- Science Translational Medicine, 2010, v. 2, n. 25, p. 1, doi. 10.1126/scitranslmed.3000759
- By:
- Publication type:
- Article
MyD88 in osteoclast and osteoblast lineages differentially controls bone remodeling in homeostasis and malaria.
- Published in:
- International Immunology, 2024, v. 36, n. 9, p. 451, doi. 10.1093/intimm/dxae023
- By:
- Publication type:
- Article
ZBP1 governs the inflammasome-independent IL-1α and neutrophil inflammation that play a dual role in anti-influenza virus immunity.
- Published in:
- International Immunology, 2020, v. 32, n. 3, p. 203, doi. 10.1093/intimm/dxz070
- By:
- Publication type:
- Article
TANK-binding kinase 1-dependent or -independent signaling elicits the cell-type-specific innate immune responses induced by the adenovirus vector.
- Published in:
- International Immunology, 2016, v. 28, n. 3, p. 105, doi. 10.1093/intimm/dxv058
- By:
- Publication type:
- Article
5,6-dimethylxanthenone-4- acetic acid (DMXAA), a partial STING agonist, competes for human STING activation.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1353336
- By:
- Publication type:
- Article
CpG oligodeoxynucleotides potentiate the antitumor activity of anti- BST2 antibody.
- Published in:
- Cancer Science, 2015, v. 106, n. 10, p. 1474, doi. 10.1111/cas.12738
- By:
- Publication type:
- Article
The Early Activation of CD8(+) T Cells Is Dependent on Type I IFN Signaling following Intramuscular Vaccination of Adenovirus Vector.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF.
- Published in:
- European Journal of Immunology, 2005, v. 35, n. 8, p. 2477, doi. 10.1002/eji.200526151
- By:
- Publication type:
- Article